Eight medical and public health groups, as well as several individual pediatricians, recently filed suit in federal court to require the U.S. Food and Drug Administration (FDA) to release a final rule that mandates graphic health warnings for cigarettes, as required by federal law in 2009.

Several health care organizations recently mailed a letter urging House appropriators to further legislative report language that would eliminate barriers that inhibit solutions for matching patients to their medical records.

The Government Accountability Office (GAO) recently released a report about the security and protection of public health and industry information at the U.S. Food and Drug Administration (FDA).

Plans for the mega-mergers of health insurance companies are being driven by regulations included in the Affordable Care Act (ACA), according to a leading health policy analyst.

Officials with the U.S. Food and Drug Administration recently warned consumers that some homeopathic gels and tablets designed for teething could be risky for children and infants.

Leaders with the U.S. Food and Drug Administration (FDA) recently expanded its approval of Ilaris to include three new indications of rare diseases for adult as well as pediatric patients.

The U.S. Food and Drug Administration (FDA) recently approved a Biologics License Application (BLA) for a GlaxoSmithKline plc (GSK) sirukumab that is designed to treat rheumatoid arthritis.

The Jett Foundation, a not-for-profit organization, recently announced that the U.S. Food and Drug Administration (FDA) has approved of a new treatment for Duchenne muscular dystrophy.

The American Academy of Family Physicians (AAFP) recently stated that many patients and family physicians want shorter, better formatting for the electronic health records (EHR) related to patient visits.

Price controls on drugs will lead to less innovation and fewer life-saving medicines making it to market, according to a former senior official with the U.S. Food and Drug Administration (FDA).

Rep. Markwayne Mullin (R-OK), from the U.S. House Committee on Energy and Commerce, recently emphasized a new law that is designed to help Oklahoma residents in the fight against opioid abuse.

The American Heart Association (AHA) has created a landmark nationwide effort in its new initiative, +color, which focuses on transforming the American diet to include more fruits and vegetables.

The American Heart Association (AHA) recently released a scientific statement stating that secondhand cigarette smoke could be harmful to children’s heart health in long-lasting, significant ways, stirring experts to urge leaders to protect children against secondhand smoke.

The U.S. Food and Drug Administration (FDA) recently took proactive measures to protect children from the illegal sale of e-liquids, e-cigarettes and cigars.

The American Academy of Family Physicians (AAFP) recently encouraged leaders at the U.S. House of Representatives to pass a bill supporting family caregivers throughout the nation.

Leaders with the U.S. Food and Drug Administration (FDA) recently granted $21.8 million to help a total of 42 states implement the new produce safety rule in the FDA Food Safety Modernization Act (FSMA).

Leaders with the European Commission recently approved of ORENCIA from Bristol-Myers Squibb to treat highly active as well as progressive rheumatoid arthritis in adult patients who have not previously used methotrexate.

Eisai Co. Ltd. recently made a public statement concerning its anticancer agent, Treakisym for Injection 100 mg, which has gained approval for an additional indication of chronic lymphocytic leukemia in Japan.

Leaders with the U.S. Food and Drug Administration (FDA) recently approved Erelzi, a biosimilar to Enbrel, as a treatment for multiple inflammatory diseases within the U.S.

Officials with the U.S. Food and Drug Administration (FDA) recently approved Erelzi as a treatment for multiple inflammatory diseases, such as plaque psoriasis, rheumatoid arthritis, psoriatic arthritis, polyarticular juvenile idiopathic arthritis and ankylosing spondylitis.